{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:07:03Z","timestamp":1792084023361,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:00:00Z","timestamp":1423526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12881-015-0146-5","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T18:22:42Z","timestamp":1423506162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation"],"prefix":"10.1186","volume":"16","author":[{"given":"Said","family":"Farschtschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor-Felix","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Hollants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Spaepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Legius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Brems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,10]]},"reference":[{"issue":"4","key":"146_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrc2109","volume":"7","author":"S Schubbert","year":"2007","unstructured":"Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007;7(4):295\u2013308.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"146_CR2","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1172\/JCI28163","volume":"116","author":"C Hafner","year":"2006","unstructured":"Hafner C, van Oers JMM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, et al. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest. 2006;116(8):2201\u20137.","journal-title":"J Clin Invest"},{"issue":"33","key":"146_CR3","doi-asserted-by":"publisher","first-page":"13450","DOI":"10.1073\/pnas.0705218104","volume":"104","author":"C Hafner","year":"2007","unstructured":"Hafner C, L\u00f3pez-Knowles E, Luis NM, Toll A, Baselga E, Fern\u00e1ndez A, et al. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A. 2007;104(33):13450\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"146_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jmedgenet-2011-100637","volume":"49","author":"C Hafner","year":"2012","unstructured":"Hafner C, Toll A, Gantner S, Mauerer A, Lurkin I, Acquadro F, et al. Keratinocytic epidermal nevi are associated with mosaic RAS mutations. J Med Genet. 2012;49(4):249\u201353.","journal-title":"J Med Genet"},{"issue":"7","key":"146_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ng.2316","volume":"44","author":"L Groesser","year":"2012","unstructured":"Groesser L, Herschberger E, Ruetten A, Ruivenkamp C, Lopriore E, Zutt M, et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet. 2012;44(7):783\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"146_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4161\/cc.23108","volume":"12","author":"C Hafner","year":"2013","unstructured":"Hafner C, Groesser L. Mosaic RASopathies. Cell Cycle. 2013;12(1):43\u201350.","journal-title":"Cell Cycle"},{"issue":"6","key":"146_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1399-0004.2011.01764.x","volume":"81","author":"DR Bertola","year":"2012","unstructured":"Bertola DR, Pereira AC, Brasil AC, Suzuki L, Leite C, Falzoni R, et al. Multiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship? Clin Genet. 2012;81(6):595\u20137.","journal-title":"Clin Genet"},{"key":"146_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","volume":"164A","author":"KM Keppler-Noreuil","year":"2014","unstructured":"Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, Parker VE, Blumhorst C, Darling T, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet Part A. 2014;164A:1713\u201333.","journal-title":"Am J Med Genet Part A"},{"issue":"12","key":"146_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/jmg.2009.075374","volume":"47","author":"F Bourdeaut","year":"2010","unstructured":"Bourdeaut F, H\u00e9rault A, Gentien D, Pierron G, Ballet S, Reynaud S, et al. Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma. J Med Genet. 2010;47(12):859\u201362.","journal-title":"J Med Genet"},{"issue":"20","key":"146_CR10","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1056\/NEJMc1109381","volume":"365","author":"C Hafner","year":"2011","unstructured":"Hafner C, Toll A, Real FX. HRAS mutation mosaicism causing urothelial cancer and epidermal nevus. N Engl J Med. 2011;365(20):1940\u20132.","journal-title":"N Engl J Med"},{"issue":"1","key":"146_CR11","doi-asserted-by":"publisher","first-page":"E132","DOI":"10.1210\/jc.2013-2813","volume":"99","author":"E Avitan-Hersh","year":"2014","unstructured":"Avitan-Hersh E, Tatur S, Indelman M, Gepstein V, Shreter R, Hershkovitz D, et al. Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23. J Clin Endocrinol Metab. 2014;99(1):E132\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2350-12-79","volume":"12","author":"A Bygum","year":"2011","unstructured":"Bygum A, Fagerberg CR, Clemmensen OJ, Fiebig B, Hafner C. Systemic epidermal nevus with involvement of the oral mucosa due to FGFR3 mutation. BMC Med Genet. 2011;12:79.","journal-title":"BMC Med Genet"},{"issue":"6","key":"146_CR13","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1365-2133.2007.07869.x","volume":"156","author":"B Collin","year":"2007","unstructured":"Collin B, Taylor IB, Wilkie AOM, Moss C. Fibroblast growth factor receptor 3 (FGFR3) mutation in a verrucous epidermal naevus associated with mild facial dysmorphism. Br J Dermatol. 2007;156(6):1353\u20136.","journal-title":"Br J Dermatol"},{"issue":"17","key":"146_CR14","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/ajmg.a.32429","volume":"146","author":"A Garc\u00eda-Vargas","year":"2008","unstructured":"Garc\u00eda-Vargas A, Hafner C, P\u00e9rez-Rodr\u00edguez AG, Rodr\u00edguez-Rojas LX, Gonz\u00e1lez-Esqueda P, Stoehr R, et al. An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation. Am J Med Genet A. 2008;146(17):2275\u20139.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"146_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2133.2012.10812.x","volume":"167","author":"LB Ousager","year":"2012","unstructured":"Ousager LB, Bygum A, Hafner C. Identification of a novel S249C FGFR3 mutation in a keratinocytic epidermal naevus syndrome. Br J Dermatol. 2012;167(1):202\u20134.","journal-title":"Br J Dermatol"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-015-0146-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-015-0146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-015-0146-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-015-0146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T08:04:24Z","timestamp":1630569864000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-015-0146-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,10]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["146"],"URL":"https:\/\/doi.org\/10.1186\/s12881-015-0146-5","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,10]]},"assertion":[{"value":"28 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}